WHO ICTRP trial

Blackmores Memory (ARCLI II): Investigating the safety and efficacy of a…

ACTRN12619000112167 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12619000112167
Public title Blackmores Memory (ARCLI II): Investigating the safety and efficacy of a Blackmores micronutrient formula on cognitive function in healthy adults aged 50-75 years.
Scientific title Investigating the safety and efficacy of acute and chronic administration of Blackmores’ ARCLI proprietary formula on cognitive function and mood in healthy adults
Primary sponsor Blackmores Ltd
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Interventional
Phase Phase 3
Countries Australia
Conditions Cognitive function;Mood;Cardiovascular function;Brain function; Cognitive function Mood Cardiovascular function Brain function;Mental Health - Studies of normal psychology, cognitive function and behaviour;Cardiovascular - Normal…
Interventions Blackmores' Micronutrient formulation: The excipient ingredients of the active formulation have been kept private at the request of the sponsor. The micronutrient formulation contains 12.5mg Pyridoxine Hydrochloride, 200mcg Folic Acid…
Registration date Jan 24, 2019
Target size 120
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations